This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

$5 Stocks That Analysts Expect to Double

3. Biodel (BIOD) shares rose in late June after the company announced positive results of a clinical study of its rapid-acting VIAject diabetes injection. On July 12, Biodel said preclinical tests of its glucose-regulated or "smart" basal insulin product candidate, BIOD620, suggests the company has "developed a new form of basal insulin that adjusts automatically to changing glucose levels."

Share Price: $3.90 (July 30 close)

Average Price Target: Just below $16, based on three analyst price targets of $17, $14 and $15 dating to June 14. Based on Biodel's current share price, analysts on average see upside of 295%.

2010 Performance: -10.1%

Analysts' View: Seven analysts cover Biodel and five of those research firms, including Cantor Fitzgerald and JPMorgan, rate the stock a "buy." On June 29, Ladenburg Thalmann analyst Matthew Kaplan reiterated his "buy" rating and $14 price target, arguing that "regulatory clarity may trigger a potential development and/or commercialization partnership."
3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BIOD $0.26 0.00%
CYTK $6.85 0.00%
GSI $1.10 0.00%
MNOV $4.22 0.00%
OREX $1.65 0.00%


Chart of I:DJI
DOW 15,660.18 -254.56 -1.60%
S&P 500 1,829.08 -22.78 -1.23%
NASDAQ 4,266.8370 -16.7550 -0.39%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs